The new Moderna COVID vaccine, mNexspike, is approved for adults 65 and older and people 12 to 64 with an underlying medical ...

The most widely used COVID-19 vaccines may offer a surprise benefit for some cancer patients by boosting their immune systems ...

Biontech Se Sponsored Adr (($BNTX)) announced an update on their ongoing clinical study. Pfizer Inc. and BioNTech SE have ...

This finding, in conjunction with the University of Texas MD Anderson Cancer Center, comes as the DeSantis administration ...

New research shows Moderna and Pfizer’s mRNA vaccines may prime the immune system to attack cancer—even better than some ...

Getting a COVID shot might do more than protect against the virus – it could also help cancer patients live longer. A new ...

Pfizer Singapore and BioNTech SE (Nasdaq: BNTX, "BioNTech") today announced that the Health Sciences Authority has approved ...

A substantial body of evidence supports the safety of the COVID-19 vaccines during pregnancy, contrary to the suggestions of ...

Pfizer's new COVID vaccine shows promising results with 4x immunity boost, but Kennedy's restrictions leave most Americans ...

Alongside the new COVID-19 vaccination guidelines, the CDC has made adjustments to its recommendations for toddler ...

Pfizer and BioNTech have begun a clinical trial for their Omicron-specific COVID-19 vaccine candidate, they announced in a news release on Tuesday. The study will evaluate the vaccine for safety, ...

Stone jauntily observes: "5 billion of us got Covid vaccines. Apparently we all have 2 months left to live. Better make the ...